WO2002030948A2 - A composition and method for preparing amino acid chelates free of interfering ions - Google Patents
A composition and method for preparing amino acid chelates free of interfering ions Download PDFInfo
- Publication number
- WO2002030948A2 WO2002030948A2 PCT/US2001/031758 US0131758W WO0230948A2 WO 2002030948 A2 WO2002030948 A2 WO 2002030948A2 US 0131758 W US0131758 W US 0131758W WO 0230948 A2 WO0230948 A2 WO 0230948A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- amino acid
- metal
- ligand
- chelate
- molar ratio
- Prior art date
Links
- 0 CS(**1*)(O[N+]([O-])[Mn](C)*)O[N+]1[O-] Chemical compound CS(**1*)(O[N+]([O-])[Mn](C)*)O[N+]1[O-] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
Definitions
- the present invention relates to compositions and methods of preparing a ino acid chelates that are essentially free of interfering ions with the proviso a hydroxide ion is not considered to be interfering.
- amino acid chelates that are electrically neutral and do not contain hydroxide complex ions can also be formed.
- -Ainino acid chelates are generally produced by the reaction between ⁇ - amino acids and metal ions having a valence of two or more to form a ring structure.
- the positive electrical charge of the metal ion is neutralized by the electrons available through the carboxylate or free amino groups of the ⁇ -- ⁇ mino acid.
- chelate has been loosely representeded as a combination of a metallic ion bonded to one or more ligands forming heterocyclic ring structures. Under this definition, chelate formation through neutralization of the positive charges of the divalent metal ions may be through the formation of ionic, covalent, or coordinate covalent bonding.
- An alternative and more modern definition of the term "chelate” requires that the metal ion be bonded to the ligand solely by coordinate covalent bonds forming a heterocyclic ring. In either case, both definitions describe a metal ion and a ligand fo ⁇ ning a heterocyclic ring.
- a chelate is a definite structure resulting from precise requirement of synthesis. Proper conditions must be present for chelation to take place, including proper mole ratios of ligands to metal ions, pH, and solubility of reactants. For chelation to occur, all components are generally dissolved in solution and are either ionized or of appropriate electronic configuration in order for coordinate covalent bonding and/or ionic bonding between the ligand and the metal ion to occur.
- Chelation can be confirmed and differentiated from mixtures of components by infrared spectra through comparison of the stretching of bonds or shifting of absorption caused by bond formation.
- the first is referred to as a "metal proteinate.”
- the American Association of Feed Control officials AAFCO has defined a "metal proteinate” as the product resulting from the chelation of a soluble salt with an-ino acids and/or partially hydrolyzed protein.
- Such products are referred to as the specific metal proteinate, e.g., copper proteinate, zinc proteinate, etc.
- metal proteinates are even referred to as amino acid chelates, though this characterization is not accurate. This is because by definition, a metal proteinate must contain partially hydrolyzed proteins which may or may not be mixed with amino acids.
- the second product when properly formed, is a stable product having one or more five-membered rings formed by a reaction between the carboxyl oxygen, and the ⁇ -ar ⁇ ino group of an ⁇ -amino acid with the metal ion.
- a five-membered ring is defined by the metal atom, the carboxyl oxygen, the carbonyl carbon, the ⁇ -carbon and the ⁇ -amino nitrogen.
- the ligand to metal mole ratio is at least 1 : 1 and is preferably 2: 1 or 3: 1. However, in certain instances, the ratio may be 4: 1. Most typically, an amino acid chelate may be represented at a ligand to metal molar ratio of 2: 1 according to Formula 1 as follows:
- the dashed lines represent coordinate covalent bonds, covalent bonds, or ionic bonds.
- the solid lines between the ⁇ -amino group and the metal (M) are covalent or coordinate covalent bonds.
- the -imino acid is glycine which is the simplest of the ⁇ -amino acids.
- R could be a radical forming any other of the other twenty or so naturally occurring amino acids derived from proteins. All of the amino acids have the same configuration for the positioning of the carboxyl oxygen and the ⁇ -amino nitrogen with respect to the metal ion.
- the chelate ring is defined by the same atoms in each instance, even though the R group may vary.
- AAFCO American Association of Feed Control Officials
- amino acid chelates It is officially defined as the product resulting from the reaction of a metal ion from a soluble metal salt with amino acids having a mole ratio of one mole of metal to one to three (preferably two) moles of amino acids to form coordinate covalent bonds.
- the average weight of the hydrolyzed amino acids must be approximately 150 and the resulting molecular weight of the chelate must not exceed 800.
- the products are identified by the specific metal forming the chelate, e.g., iron amino acid chelate, copper amino acid chelate, etc.
- a metal atom can accept bonds over and above the oxidation state of the metal is due to the nature of chelation.
- the nitrogen contributes both of the electrons used in the bonding. These electrons fill available spaces in the d-orbitals fo ⁇ ning a coordinate covalent bond.
- a metal ion with a normal valency of +2 can be bonded by four bonds when fully chelated. In this state, the chelate is completely satisfied by the bonding electrons and the charge on the metal atom (as well as on the overall molecule) is zero.
- the metal ion be bonded to the carboxyl oxygen by either coordinate covalent bonds or ionic o bonds.
- the metal ion is typically bonded to the ⁇ -amino group by coordinate covalent bonds only.
- -Amino acid chelates can also be formed using small peptide ligands instead of single amino acids. These will usually be in the form of dipeptides, tripeptides, and sometimes tetrapeptides because larger ligands have molecular weights that are too great for direct cellular assimilation of the chelate formed. Generally, peptide ligands will be derived by the hydrolysis of protein. However, peptides prepared by conventional synthetic techniques or genetic engineering can also be used. When a ligand is a di- or tripeptide, a radical of the formula [C(O)CHRNH] e H will replace one of the hydrogens attached to the nitrogen atom in Formula 1.
- R as defined in Formula 1 , can be H, or the residue of any other naturally occurring amino acid and e can be an integer of 1, 2 or 3.
- e can be an integer of 1, 2 or 3.
- amino acid chelates in the field of mineral nutrition is attributed to the fact that these chelates are readily absorbed in the absorptive mucosal cells or plant cells by means of active transport or other know mechanisms.
- the minerals are absorbed along with the amino acids as a single unit utilizing the amino acids as carrier molecules. Therefore, the problems associated with the competition of ions for active sites and the suppression of specific nutritive mineral elements by others are avoided. This is especially true for compounds such as iron sulfates that must be delivered in relatively large quantities in order for the body or plant to absorb an appropriate amount. This is significant because large quantities often cause nausea and other gastrointestinal discomforts in animals as well as create an undesirable taste. Additionally, in plants, large amounts of these compounds can act to burn leaves and cause other undesirable results.
- a ino acid chelates have generally been made by first dissolving a water soluble metal salt in water. An amino acid ligand is then reacted with the metal ion at a ratio of ligand to metal from 1 : 1 to 4: 1 , preferably 2: 1.
- the ligand is a hydrolysis product obtained by acid, base, base-acid, base-acid-base, or enzyme hydrolysis.
- the by products from hydrolysis such as anions including chlorides, sulfates, phosphates and nitrates, and cations including potassium and sodium, remain in the hydrolysate. Reaction products of metal salts with proteins or with acid and/or base hydrolyzed proteins are taught in U.S.
- the sulfate interferes with the total reaction and abso ⁇ tion of the chelate.
- Such products are difficult to purify. While sodium sulfate, per se, is water soluble, the reaction between a metal sulfate and an amino acid is never carried to 100% completion and the sulfate ion is always present. The same holds true for the presence of chloride ions when utilizing a metal chloride salt for arnino acid chelate preparation.
- the present invention can comprise compositions and methods of manufacturing electrically neutral amino acid chelates free of interfering ions.
- These amino acid chelates are prepared by reacting an calcium oxide and/or hydroxide, an amino acid, and a soluble metal sulfate salt in an aqueous solution at a ratio sufficient to allow substantially all of the ions present in solution to react.
- a metal amino acid chelate, calcium sulfate, and water are formed with substantially no interfering ions.
- the metal arnino acid chelates produced will have a ligand to metal molar ratio from about 2: 1 to 3 : 1 , depending on the valency of the metal, e.g., Fe(II) forms 2: 1 and Fe(III) forms 3:1.
- the present invention can also comprise compositions and methods of manufacturing amino acid chelates free of interfering ions.
- a ino acid chelates are prepared by reacting calcium oxide or hydroxide, an arnino acid, and a soluble metal sulfate salt in an aqueous environment at a ratio sufficient to allow substantially all of the potentially interfering ions present in solution to react.
- a positively charged metal arnino acid chelate having a hydroxide counter ion present, an essentially insoluble calcium sulfate salt, and optionally, water are formed without the presence of interfering ions.
- a hydroxide anion is not considered to be interfering.
- the metal amino acid chelates produced will have a ligand to metal molar ratio from about 1 : 1 to 2: 1, depending on the valency of the metal, e.g., Fe(II) forms 1 : 1 and Fe(III) forms 2: 1.
- Electrode neutral refers to the amino acid chelate of the reaction in • ' which essentially all of the reactants have formed product such that there is no net charge on the a ino acid chelate itself.
- Embodiments where the amino acid chelate is positively charged and is complexed to a hydroxide counter ion are not considered to be electrically neutral, even though the net charge of the entire complex, i.e., amino acid chelate and hydroxide ion, is neutral.
- Interfering ion is meant to include any cation or anion which would hinder the formation of the amino acid chelate and which remains in the composition as a charged ion that has not reacted to form an amino acid chelate, calcium sulfate, or water.
- "interfering ion” can include any cation or anion which would hinder the formation of the amino acid chelate and which remains in the composition as a charged ion that has not reacted to form either the charged amino acid chelate having a hydroxide counter- ion or the calcium sulfate salt.
- a hydroxide anion which is preferably complexed to the positively charged amino acid chelate is not considered to be an interfering ion.
- Metal arnino acid chelate or “arnino acid chelate” includes metal ions bonded to amino acid ligands forming heterocyclic rings. The bonds may be coordinate covalent, covalent and/or ionic at the carboxyl oxygen group.
- the bond is typically a coordinate covalent bond.
- Preferred amino acids include all of the naturally occurring amino acids.
- the amino acid chelate formed is electrically neutral.
- amino acid chelate can include any charged amino acid chelate that is electrically balanced by a hydroxide counter ion.
- a trivalent cation having a ligand to metal molar ratio of 2: 1 may be represented by the formula M'(AA) 2 + OH " where M' is the trivalent metal and AA is an amino acid.
- a divalent cation having a ligand to metal molar ratio of 1: 1 may be represented by the formula M(AA) + OH " where M is the divalent metal and AA is an amino acid. If the amino acid chelate as a whole is in solution, the hydroxide anion and the charged chelate may be in solution or complexed together. If the amino acid chelate has been dried, the hydroxide anion and the charged chelate will likely be complexed.
- Metal is meant to cover all nutritionally relevant metals that are more soluble as sulfate salts than calcium sulfate. Though calcium is a metal, for purposes of the present disclosure, calcium is specifically excluded within this definition unless the context clearly dictates otherwise.
- Soluble metal sulfate or “soluble metal sulfate salt” include all divalent or trivalent metals that are more soluble than calcium sulfate when in the form of a sulfate salt.
- Preferred soluble metal sulfate salts can comprise at least one nutritionally relevant metal.
- “Nutritionally relevant metals” include metals that are known to be needed by living organisms, particularly plants and mammals, including humans. Metals such as copper (Cu), zinc (Zn), iron (Fe), cobalt (Co), magnesium (Mg), manganese (Mn), and/or chromium (Cr), among others, are exemplary of nutritionally relevant metals.
- the present invention includes compositions and methods of manufacturing electrically neutral amino acid chelates free of interfering ions.
- These chelates are prepared by reacting 1) calcium oxide and/or hydroxide, 2) one or more amino acid, and 3) a soluble metal sulfate salt in an aqueous solution at a ratio sufficient to allow substantially all of the ions present in solution to react fom ⁇ ig a metal amino acid chelate, calcium sulfate, and water, and wherein the metal amino acid chelate has a ligand to metal molar ratio from about 2 : 1 to 3 : 1.
- the present invention includes compositions and methods of manufacturing amino acid chelates free of interfering ions.
- These chelates are prepared by reacting 1) a calcium oxide or hydroxide, 2) an amino acid, and 3) a soluble metal sulfate salt in an aqueous environment at a ratio sufficient to allow substantially all of the ions present in solution to react forming a positively charged metal amino acid chelate having a hydroxide counter-ion, a calcium sulfate salt, and optionally, water.
- the metal amino acid chelates of the present invention will have a ligand to metal molar ratio from about 1 : 1 to 2: 1.
- compositions and methods of the present invention provide arnino acid chelates free of interfering ions
- calcium sulfate is always a byproduct. Therefore, the calcium sulfate may be substantially separated out of the compound by methods commonly known in the art. Alternatively, the calcium sulfate may remain in the compound as a stabilizer or for other purposes as described herein.
- the present invention also encompasses drying of the chelate solution when appropriate to provide a powder for some uses, e.g., human, animal, and plant nutrition. However, with some applications, it may be desired that the chelate remain in solution, e.g., foliar use.
- any conventional drying technique as is known in the art may be used. For example, if spray drying, bulk density of the powder produced in a spray dryer is affected by the mesh size of the nozzles in the dryer, the pump pressure, and the percent of total solids in the solution to be dried. In general, the higher the total solids, the greater the bulk density of the resulting powder. A greater bulk density also reduces the electrostatic properties of the spray dried powder. For example, the presence of the calcium sulfate (terra alba) suspended in the metal amino acid chelate solution by continual agitation will increase the total solids to be dried, thus, increasing the ultimate bulk density of the dried chelate.
- the increased bulk density of the dried product may have at least three distinct advantages.
- First, the dried product is less hygroscopic due to the increased density and due to the fact that calcium sulfate salt is less hygroscopic than the arnino acid chelate, which through the drying process have waters of hydration removed.
- the amino acid to be used can be one or more of the naturally occurring amino acid selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, cystine, glutamine, glutamic acid, glycine, histidine, hydroxyproline, isoleucine, leucine, lysine, methionine, ornithine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, and combinations thereof.
- dipeptides, tripeptides, and tetrapeptides formed by any combination of the naturally occurring arnino acids can also be used.
- the metal is preferably more soluble as a sulfate salt than calcium sulfate.
- Exemplary metals for use can include those selected from the group consisting of Cu, Zn, Fe, Cr, Co, Mg, Mn, and combinations thereof.
- the metal reactant is preferably provided as a sulfate salt selected from the group consisting of copper sulfate (CuSO 4 ), zinc sulfate (ZnSO 4 ), ferrous sulfate (FeSO 4 ), manganese sulfate (MnSO 4 ), cobalt sulfate (CoSO 4 ), magnesium sulfate (MgSO 4 ), ferric sulfate [Fe 2 (SO 4 ) 3 ], chromic sulfate [Cr 2 (SO 4 ) 3 ], and combinations thereof.
- a sulfate salt selected from the group consisting of copper sulfate (CuSO 4 ), zinc sulfate (ZnSO 4 ), ferrous sulfate (FeSO 4 ), manganese sulfate (MnSO 4 ), cobalt sulfate (CoSO 4 ), magnesium sulfate (MgSO 4 ), ferric sulfate [
- Step A involves the reaction of one or more amino acid(s) with a soluble calcium oxide and/or hydroxide in an aqueous solution fo ⁇ ning a calcium arnino acid chelate or complex product.
- the calcium is displaced by the metal forming an electrically neutral amino acid chelate having a ligand to metal molar ratio from 2: 1 to 3: 1.
- the calcium is displaced by the metal forming an amino acid chelate having a ligand to metal molar ratio from 1 : 1 to 2: 1 , and having a hydroxide counter ion.
- the calcium reacts with the sulfate anion to form an inert and highly insoluble calcium sulfate precipitate.
- H(AA) is an amino acid selected from the group consisting of naturally occurring amino acids and combinations thereof.
- H when disassociated from AA, is a hydrogen ion donor from the carboxyl group present on the amino acid.
- M is a nutritionally relevant metal having a valency of +2 (excluding calcium) such as Cu, Zn, Fe, Co, Mg, and/or Mn.
- the reactants i.e., CaO, H(AA), and MSO 4
- the reactants may be added in any order.
- all three reactants may be added simultaneously or the amino acid and the soluble metal salt may be added before the calcium oxide or hydroxide.
- the above equation must be balanced so that the final products, M(AA) 2 , CaSO 4 , and water, are free of interfering ions such that the amino acid chelate is electrically neutral. Therefore, notwithstanding Formula 3 a and 3b which illustrates a preferred mechanism, the general formula of the present invention when a 2: 1 ligand to metal molar ratio is desired may be represented by Formulas 4a and 4b as follows:
- metals having a proper valency state should be used, e.g., Cu, Zn, Fe(II), Co, Mg, and/or Mn for amino acid chelates having a ligand to metal molar ratio of about 2: 1.
- General Formulas 4a and 4b above may be modified to prepare amino acid chelates having a ligand to metal molar ratio of about 3 : 1 using metals having a valency of +3, e.g., Fe(III), Cr, etc.
- the general formula of the present invention when a 3: 1 ligand to metal molar ratio is desired may be represented by Formulas 5a and 5b as follows:
- H(AA) is an amino acid selected from the group consisting of naturally occurring amino acids and combinations thereof.
- H when disassociated from AA, is a hydrogen ion donor from the carboxyl group present on the amino acid.
- M' is a nutritionally relevant metal having a valence of +3 such as Fe(III) and/or Cr.
- compositions and methods of the present invention provide electrically neutral amino acid chelates free of interfering ions
- calcium sulfate is always a byproduct. Therefore, the calcium sulfate may be substantially separated out of the compound by methods commonly known in the art while the chelate is still in solution. Alternatively, the calcium sulfate may remain in the compound as a stabilizer or for other purposes.
- (H)AA is an amino acid selected from the group consisting of naturally occurring amino acids and combinations thereof.
- H when disassociated from AA, is a hydrogen ion donor from the carboxyl group present on the amino acid.
- M is a nutritionally relevant metal having a valency of +2 (excluding calcium) such as Cu, Zn, Fe, Co, Mg, and/or Mn.
- the added reactants i.e., CaO or Ca(OH) 2 , H(AA), and MSO 4
- the added reactants may be added in any order.
- all three reactants may be added simultaneously or the amino acid and the soluble metal sulfate salt may be added before the calcium oxide or hydroxide.
- the above equation must be balanced to account for all of the potential interfering ions so that the final product (which includes M(AA) + OH " + CaSO 4 ) is free of interfering ions. Therefore, notwithstanding Formula 6a and 6b which illustrates the above mechanism, the general formula of the present invention when a 1: 1 ligand to metal molar ratio is desired may be represented by Formulas 7a and 7b below:
- metals with proper oxidation states or valency should be used, e.g., Cu, Zn, Fe(II), Co, Mg, and/or Mn when producing amino acid chelates having a ligand to metal molar ratio of about 1: 1.
- General Formulas 7a and 7b above may be modified to prepare arnino acid chelates having a ligand to metal molar ratio of about 2: 1 using nutritionally relevant metals having a valency of +3, e.g., Fe(III), Cr, etc.
- the general formula of the present invention when a 2: 1 ligand to metal molar ratio is desired may be represented by Formulas 8a and 8b below:
- H(AA) is an amino acid selected from the group consisting of naturally occurring amino acids and combinations thereof; H, when disassociated from AA, is a hydrogen ion donor from the carboxyl group present on the amino acid.
- M' is a nutritionally relevant metal having a valence of +3 such as Fe(III) and/or Cr.
- composition examples described herein provide an amount of chelate product produced in solution. However, often, the step of drying, i.e., removing moisture, from a chelate solution may be preferred. Additionally, prior to drying, calcium sulfate (terra alba) may be substantially removed by separation techniques known by those skilled in the art if desired.
- Example 2 Preparation of zinc glycine amino acid chelate About 250 grams of glycine was dissolved into 937.8 grams of water.
- Example 3 The procedure of Example 3 may be followed using 100.82 grams of calcium hydroxide instead of 76.38 grams calcium oxide with similar results, i.e., about 277 grams of a manganese bisglycinate is formed, though more water is formed in the reaction.
- magnesium sulfate hydrate containing 9.86% magnesium by weight was added to the calcium chelate solution.
- the solution was stirred while the magnesium sulfate dissolved and a white precipitate of calcium sulfate formed.
- About 211 grams of a magnesium glycinate was formed having a 1 : 1 ligand to metal molar ratio.
- Example 8 Preparation of copper, zinc, and manganese amino acid chelate mixture About 2400 grams of water was used to dissolve 475 grams of glycine. Next, 175 grams of calcium oxide, which was 70% calcium by weight, was stirred into the aqueous solution. The solution was continually stirred for about 15 minutes until all of the calcium oxide was dissolved and a calcium bisglycinate chelate or complex solution was formed.
- Example 9 Preparation of copper, zinc, manganese, and iron amino acid chelate mixture To about 2600 grams of water was stirred 455 grams of glycine and 173 grams of calcium oxide. Once the glycine and calcium oxide had dissolved, a calcium bisglycinate chelate or complex solution was formed.
- Example 11 Preparation of ferrous glycine amino acid chelate To about 1300 grams of water was added about 382 grams of ferrous sulfate containing 20% Fe(II) by weight. The solution was stirred until the ferrous sulfate dissolved. Next, about 211 grams of glycine was stirred into the solution for about 30 minutes. To the aqueous solution was added about 80 grams of calcium oxide. Again the solution was continually stirred until all of the CaO was dissolved. As the calcium oxide went into solution, a white precipitate of calcium sulfate as well as about 287 grams of a ferrous glycine chelate having a ligand to metal molar ratio of 2: 1 was formed.
- Example 12 Preparation of chromium glycine amino acid chelate About 2252 grams of water was used to dissolve 450.42 grams of glycine and 168.24 grams of calcium oxide into solution. The resulting reaction formed a calcium trisglycinate chelate or complex solution.
- Example 13 Preparation of chromium glycine amino acid chelate The procedure of Example 12 may be followed using 222.08 grams of calcium hydroxide instead of 168.24 grams calcium oxide with similar results, i.e., about 545 grams of a chromic trisglycinate is formed.
- a reaction mixture was prepared comprising 33.96 grams of calcium oxide, 108.09 grams of alanine, and 700 grams of water. The mixture was stirred for 15 minutes. Next, 301.83 grams of copper sulfate pentahydrate was added to the reaction mixture. As the solution was further stirred, a white precipitate of calcium sulfate formed. Once the reaction was complete, 205.15 grams of a copper alanine amino acid chelate having a ligand to metal molar ratio of about 1: 1 remained in solution.
- a solution was prepared containing 58.23 grams of calcium oxide, 218.18 grams of serine, and 700 grams of water. The reaction mixture was stirred for about 15 minutes while the reaction advanced. Next, 261.89 grams of ferrous sulfate pentahydrate was added to the reaction mixture and stirred for about 15 minutes. In addition to the calcium sulfate precipitate (terra alba) produced,
- Example 17 Preparation of copper lysine amino acid chelate
- a reaction mixture comprised of 5.58 grams of calcium oxide, 32.66 grams of lysine monohydrate, and 700 grams of water was prepared and allowed to react while stirring for 30 minutes.
- 49.94 grams of copper sulfate pentahydrate was added and stirred until the reaction appeared complete.
- a white precipitate of calcium sulfate formed during the reaction.
- the reactants produced 45.14 grams of a copper lysine amino acid chelate having a ligand to metal molar ratio of about 1: 1.
- Example 18 Preparation of zinc cysteine/glycine amino acid chelate A solution comprising 56.08 grams of calcium oxide, 60.58 grams of cysteine, 37.53 grams of glycine, and 700 grams of water was prepared and allowed to react for 30 minutes while being stirred. Next, 161.44 grams of zinc sulfate was added and stirred until the zinc sulfate dissolved. In addition to the formation of the terra alba, 179.49 grams of a zinc cysteine/glycine amino acid chelate having a ligand to metal molar ratio of about 1 : 1 was formed.
- a reaction mixture comprised of 74.1 grams of calcium hydroxide, 105.1 grams of serine, and 700 grams of water was prepared and allowed to react for 30 minutes while stirring. Next, 249.6 grams of copper sulfate pentahydrate was stirred into the solution and a white precipitate of calcium sulfate formed. Once the reaction was complete, a total of 184.7 grams of a copper serine a ino acid chelate having a ligand to metal molar ratio of about 1 : 1 was produced.
- Example 22 Preparation of copper glycine amino acid chelate To about 1500 grams of water was dissolved 150.14 grams of glycine,
- Sample 1 was further compared to Sample 2 by rubbing a portion of each between the thumb and finger. Sample 2 quickly balled up with moisture from the thumb and finger as well as from the surrounding air. Conversely, Sample 1 did not ball up. This demonstrated that Sample 1 was less hygroscopic.
- Sample 2 was added to a stimulated gastric solution which caused the product to change color.
- Sample 1 was similarly added to a stimulated gastric solution. However, no color change was observed demonstrating the stabilizing effect of terra alba on an amino acid chelate in an acid environment.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002425473A CA2425473A1 (en) | 2000-10-11 | 2001-10-10 | A composition and method for preparing amino acid chelates free of interfering ions |
EP01981466A EP1325012A4 (en) | 2000-10-11 | 2001-10-10 | A composition and method for preparing amino acid chelates free of interfering ions |
AU2002213106A AU2002213106A1 (en) | 2000-10-11 | 2001-10-10 | A composition and method for preparing amino acid chelates free of interfering ions |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/686,684 | 2000-10-11 | ||
US09/686,046 | 2000-10-11 | ||
US09/686,046 US6458981B1 (en) | 2000-10-11 | 2000-10-11 | Composition and method for preparing amino acid chelate hydroxides free of interfering ions |
US09/686,684 US6407138B1 (en) | 2000-10-11 | 2000-10-11 | Composition and method for preparing electrically neutral amino acid chelates free of interfering ions |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002030948A2 true WO2002030948A2 (en) | 2002-04-18 |
WO2002030948A3 WO2002030948A3 (en) | 2002-07-18 |
Family
ID=27103727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/031758 WO2002030948A2 (en) | 2000-10-11 | 2001-10-10 | A composition and method for preparing amino acid chelates free of interfering ions |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1325012A4 (en) |
AU (1) | AU2002213106A1 (en) |
CA (1) | CA2425473A1 (en) |
WO (1) | WO2002030948A2 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003092674A1 (en) * | 2002-05-02 | 2003-11-13 | Integrity Pharmaceutical Corporation | Prenatal multivitamin/multimineral supplement |
EP1366664A1 (en) * | 2001-02-16 | 2003-12-03 | Murakashi Lime Industry Co., Ltd | Antibacterial composition |
CN101062913B (en) * | 2007-06-05 | 2013-01-23 | 重庆大学 | Preparation method of hydroxyproline-zinc chelate complex |
CN103467331A (en) * | 2013-09-26 | 2013-12-25 | 潍坊祥维斯化学品有限公司 | Iron glycine chelate crystal growth method |
CN110330439A (en) * | 2019-07-12 | 2019-10-15 | 辽阳华路催化技术研发有限公司 | A kind of zinc-glycine complex and preparation method thereof not introducing foreign ion |
CN110734331A (en) * | 2019-10-28 | 2020-01-31 | 内蒙古阜丰生物科技有限公司 | composite fertilizer prepared by glutamic acid fermentation waste |
CN111116438A (en) * | 2019-12-25 | 2020-05-08 | 长沙兴嘉生物工程股份有限公司 | Preparation method and application of manganese cystine |
JP2020526566A (en) * | 2017-07-14 | 2020-08-31 | シージェイ チェイルジェダン コーポレーション | Methionine-metal chelate and its manufacturing method |
JP2020526563A (en) * | 2017-07-14 | 2020-08-31 | シージェイ チェイルジェダン コーポレーション | Methionine-metal chelate and its manufacturing method |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106858610B (en) * | 2017-03-01 | 2018-05-22 | 岳智广 | The preparation method of a kind of amino acid chelated calcium and including the chelated calcium calcium-supplementing preparation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3950372A (en) * | 1974-07-03 | 1976-04-13 | Zinpro Corporation | 1:1 Manganese alpha amino acid complexes |
US4425280A (en) * | 1981-03-30 | 1984-01-10 | Ferro Corporation | Metal amino acids |
US4830716A (en) * | 1986-07-03 | 1989-05-16 | Albion International, Inc. | Preparation of pharmaceutical grade amino acid chelates |
US5698724A (en) * | 1996-04-30 | 1997-12-16 | Zinpro Corporation | Amino acid metal complexes using hydrolyzed protein as the amino acid source and methods re same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292729A (en) * | 1992-08-14 | 1994-03-08 | Albion International, Inc. | II-bond aromatic vitamin chelates |
-
2001
- 2001-10-10 CA CA002425473A patent/CA2425473A1/en not_active Abandoned
- 2001-10-10 AU AU2002213106A patent/AU2002213106A1/en not_active Abandoned
- 2001-10-10 WO PCT/US2001/031758 patent/WO2002030948A2/en not_active Application Discontinuation
- 2001-10-10 EP EP01981466A patent/EP1325012A4/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3950372A (en) * | 1974-07-03 | 1976-04-13 | Zinpro Corporation | 1:1 Manganese alpha amino acid complexes |
US4425280A (en) * | 1981-03-30 | 1984-01-10 | Ferro Corporation | Metal amino acids |
US4830716A (en) * | 1986-07-03 | 1989-05-16 | Albion International, Inc. | Preparation of pharmaceutical grade amino acid chelates |
US4830716B1 (en) * | 1986-07-03 | 1999-12-07 | Albion Int | Preparation of pharmaceutical grade amino acid chelates |
US5698724A (en) * | 1996-04-30 | 1997-12-16 | Zinpro Corporation | Amino acid metal complexes using hydrolyzed protein as the amino acid source and methods re same |
Non-Patent Citations (1)
Title |
---|
See also references of EP1325012A2 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1366664A1 (en) * | 2001-02-16 | 2003-12-03 | Murakashi Lime Industry Co., Ltd | Antibacterial composition |
EP1366664A4 (en) * | 2001-02-16 | 2004-04-07 | Murakashi Lime Ind | Antibacterial composition |
WO2003092674A1 (en) * | 2002-05-02 | 2003-11-13 | Integrity Pharmaceutical Corporation | Prenatal multivitamin/multimineral supplement |
US7994217B2 (en) | 2002-05-02 | 2011-08-09 | Xanodyne Pharmaceuticals, Inc. | Prenatal multivitamin/multimineral supplement |
CN101062913B (en) * | 2007-06-05 | 2013-01-23 | 重庆大学 | Preparation method of hydroxyproline-zinc chelate complex |
CN103467331B (en) * | 2013-09-26 | 2015-01-21 | 山东祥维斯生物科技有限公司 | Iron glycine chelate crystal growth method |
CN103467331A (en) * | 2013-09-26 | 2013-12-25 | 潍坊祥维斯化学品有限公司 | Iron glycine chelate crystal growth method |
JP2020526566A (en) * | 2017-07-14 | 2020-08-31 | シージェイ チェイルジェダン コーポレーション | Methionine-metal chelate and its manufacturing method |
JP2020526563A (en) * | 2017-07-14 | 2020-08-31 | シージェイ チェイルジェダン コーポレーション | Methionine-metal chelate and its manufacturing method |
US10981937B2 (en) | 2017-07-14 | 2021-04-20 | Cj Cheiljedang Corporation | Methionine-metal chelate and manufacturing method thereof |
CN110330439A (en) * | 2019-07-12 | 2019-10-15 | 辽阳华路催化技术研发有限公司 | A kind of zinc-glycine complex and preparation method thereof not introducing foreign ion |
CN110734331A (en) * | 2019-10-28 | 2020-01-31 | 内蒙古阜丰生物科技有限公司 | composite fertilizer prepared by glutamic acid fermentation waste |
CN110734331B (en) * | 2019-10-28 | 2022-03-11 | 内蒙古阜丰生物科技有限公司 | Compound fertilizer prepared by utilizing glutamic acid fermentation waste |
CN111116438A (en) * | 2019-12-25 | 2020-05-08 | 长沙兴嘉生物工程股份有限公司 | Preparation method and application of manganese cystine |
CN111116438B (en) * | 2019-12-25 | 2022-05-20 | 长沙兴嘉生物工程股份有限公司 | Preparation method and application of manganese cystine |
Also Published As
Publication number | Publication date |
---|---|
EP1325012A4 (en) | 2005-08-10 |
CA2425473A1 (en) | 2002-04-18 |
AU2002213106A1 (en) | 2002-04-22 |
EP1325012A2 (en) | 2003-07-09 |
WO2002030948A3 (en) | 2002-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6458981B1 (en) | Composition and method for preparing amino acid chelate hydroxides free of interfering ions | |
US6407138B1 (en) | Composition and method for preparing electrically neutral amino acid chelates free of interfering ions | |
US6710079B1 (en) | Composition and method for preparing amino acid chelates and complexes free of interfering complex ions | |
JP3249129B2 (en) | Amino acid chelate with improved mouthfeel | |
EP1274419B1 (en) | Zinc amino acid chelates having ligands comprised of glycine and a sulfur-containing amino acid | |
JP2547026B2 (en) | Method for producing pharmaceutical grade amino acid chelate | |
CA2142358C (en) | .pi.-bond aromatic vitamin chelates | |
CA2457584C (en) | Enhancing solubility of iron amino acid chelates and iron proteinates | |
US6518240B1 (en) | Composition and method for preparing amino acid chelates and complexes | |
WO2002030947A2 (en) | Compositions and methods of preparing amino acid chelates and complexes | |
JP2006503092A (en) | Metal complex of α-aminodicarboxylic acid | |
EP1325012A2 (en) | A composition and method for preparing amino acid chelates free of interfering ions | |
US20070270591A1 (en) | Iron (II) amino acid chelates with reducing agents attached thereto | |
KR100481326B1 (en) | Producing process for organic chelate | |
US20090182044A1 (en) | Nitrate amino acid chelates | |
WO1996006099A1 (en) | 1,2-disubstituted aromatic chelates | |
US20080096804A1 (en) | Pure amino acid chelate complexes and uses thereof | |
CA2623964C (en) | Using metal aquacomplexes for preparation pure amino acid chelates for human and veterinary use | |
JP2002047266A (en) | Composition including methionine transition metal complex and amino acids | |
RU2764579C1 (en) | Method for producing a composition containing at least one compound of a metal with an amino acid, and composition produced by this method | |
WO2022211647A1 (en) | Method of obtaining iron chelate for use as a dietary supplement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001981466 Country of ref document: EP Ref document number: 2425473 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 2001981466 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001981466 Country of ref document: EP |